As a global leader in animal health, Ceva embraces its social responsibility to not only contribute towards animal and human welfare, but to do so in a responsible and ethical way. That is also the main goal of all our product research and development.
During this time of unprecedented environmental and global economic challenges, Ceva is working hard to create products that are safe for users, animals and consumers.
We take our responsibility to protect the environment seriously by conducting regular studies to identify the impact of animal waste on the environment.
Our research and development centres keep a close eye on the welfare of animals. All the work performed there is governed by a 12-point, ethical charter in which point 7 states that all animal studies must be submitted to the in-house ethics committee for approval.
Ceva is a visible supporter of and contributor to various welfare and social programmes.
CEVA’S CONTRIBUTION TO FEEDING THE WORLD GOES BEYOND BEING A GLOBAL LEADER IN VACCINES...
Today close to one billion people in developing countries suffer from chronic malnutrition, surviving on inadequate starch-based diets. A further two billion in emerging countries aspire to eat more diverse and nutritious diets – with more meat, milk and eggs, at the top of their wish-lists.
As well as being rich sources of high quality protein, meat, milk and eggs also supply a range of essential micro-nutrients, many of which are scarce or absent in plant-based diets. Consumption of adequate amounts of these nutrients is essential if children are to be healthy and grow and develop normally, going on to fulfil their potential as healthy and productive members of society.
By 2050, global consumption of meat will double. The vast majority of that increased demand will occur in developing countries.
Chicken meat is expected to make up almost half of the extra consumption of meat from now until the year 2022. Preventing poultry diseases and reducing death rates are important ways of boosting productivity.
Vaccination of poultry in the hatchery rather than on the farm is proving to be more effective by allowing more efficient use of renewable resources – so Ceva has made this approach one of its major development strategies.
Today, around 12 billion birds annually - one in every four broiler chickens produced in the world - are protected by Ceva’s new generation vaccines. But Ceva’s contribution to feeding the world goes well beyond simply being global leaders in animal vaccines. For example:
Ceva’s innovative reproduction-control product Altresyn® is helping Danish pig breeders (already the best in the world) to become even more efficient.
Ceva’s C.H.I.C.K. programme supports hatchery professionals in all aspects of vaccination.
Ceva’s acquisition of vaccination equipment manufacturer Desvac and its strategic partnership with Ecat, which focuses on automated handling of eggs and chicks in the hatchery, enables Ceva to offer poultry producers a wider range of vaccine services, programs and hatchery equipment.
Ceva’s support for the Sympavi symposium in Dakar, Senegal in 2013 helped to promote the idea that the future of poultry farming in Africa will depend on hatchery vaccination.
Ceva’s programme helped to inform and then launch the Perfect Pair – a combination of two different types of new generation vaccines that prevents the three major poultry diseases with a single injection.
Ceva’s support for Fondation du Patrimoine ‘Prize for Animal Agro-biodiversity’. Since 2012 this prize has recognised and rewarded individuals or groups who show commitment to preserving at-risk farm animal breeds by promoting their economic and societal value.